Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
Prostate cancer cells have an exquisite tropism for bone, which clinically translates into the highest rate of bone metastases amongst male cancers. Although in the latest years there has been an active development of new “bone targeted” therapies, modern diagnostic techniques for bone metastases st...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/893193 |
id |
doaj-290146b34d9840699778cc010227c0a5 |
---|---|
record_format |
Article |
spelling |
doaj-290146b34d9840699778cc010227c0a52020-11-24T22:58:02ZengHindawi LimitedAdvances in Urology1687-63691687-63772012-01-01201210.1155/2012/893193893193Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?Bertrand Tombal0Frederic Lecouvet1Division of Urology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, 1200 Brussels, BelgiumDivision of Radiology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, 1200 Brussels, BelgiumProstate cancer cells have an exquisite tropism for bone, which clinically translates into the highest rate of bone metastases amongst male cancers. Although in the latest years there has been an active development of new “bone targeted” therapies, modern diagnostic techniques for bone metastases still relies mostly on 99mTc bone scanning (BS) and plain X-ray. BS dramatically lacks specificity and sensitivity. Recent publications using modern imaging technologies have clearly pinpointed that BS grossly underestimates the true prevalence of bone metastasis. In addition BS does not allow tumour measurement and is, therefore, not appropriate to monitor response to therapy. This might be extremely important in patients harbouring high-risk localized disease that are eventually candidate for local therapy. Here we reviewed what are the emerging imaging strategies that are likely to supplant BS and to what extent they can be used in the clinic already.http://dx.doi.org/10.1155/2012/893193 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bertrand Tombal Frederic Lecouvet |
spellingShingle |
Bertrand Tombal Frederic Lecouvet Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over? Advances in Urology |
author_facet |
Bertrand Tombal Frederic Lecouvet |
author_sort |
Bertrand Tombal |
title |
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over? |
title_short |
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over? |
title_full |
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over? |
title_fullStr |
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over? |
title_full_unstemmed |
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over? |
title_sort |
modern detection of prostate cancer's bone metastasis: is the bone scan era over? |
publisher |
Hindawi Limited |
series |
Advances in Urology |
issn |
1687-6369 1687-6377 |
publishDate |
2012-01-01 |
description |
Prostate cancer cells have an exquisite tropism for bone, which clinically translates into the highest rate of bone metastases amongst male cancers. Although in the latest years there has been an active development of new “bone targeted” therapies, modern diagnostic techniques for bone metastases still relies mostly on 99mTc bone scanning (BS) and plain X-ray. BS dramatically lacks specificity and sensitivity. Recent publications using modern imaging technologies have clearly pinpointed that BS grossly underestimates the true prevalence of bone metastasis. In addition BS does not allow tumour measurement and is, therefore, not appropriate to monitor response to therapy. This might be extremely important in patients harbouring high-risk localized disease that are eventually candidate for local therapy. Here we reviewed what are the emerging imaging strategies that are likely to supplant BS and to what extent they can be used in the clinic already. |
url |
http://dx.doi.org/10.1155/2012/893193 |
work_keys_str_mv |
AT bertrandtombal moderndetectionofprostatecancersbonemetastasisisthebonescaneraover AT fredericlecouvet moderndetectionofprostatecancersbonemetastasisisthebonescaneraover |
_version_ |
1725648647949910016 |